MULTIFUNKTIONELLE PROTEASE-INHIBITOREN UND DEREN VERWENDUNG ZUR BEHANDLUNG VON KRANKHEITEN

Fusion proteins of protease inhibitors are provided, in particular fusion proteins of alpha 1-antitrypsin (AAT) and a second protease inhibitor, such as secretory leukocyte protease inhibitor (SLPI) or tissue inhibitor of metalloproteases (TIMP). Polynucleotides encoding the fusion proteins, vectors...

Full description

Saved in:
Bibliographic Details
Main Authors PEMBERTON, PHILIP, BARR, PHILIP J, GIBSON, HELEN L
Format Patent
LanguageGerman
Published 22.01.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fusion proteins of protease inhibitors are provided, in particular fusion proteins of alpha 1-antitrypsin (AAT) and a second protease inhibitor, such as secretory leukocyte protease inhibitor (SLPI) or tissue inhibitor of metalloproteases (TIMP). Polynucleotides encoding the fusion proteins, vectors comprising such polynucleotides, and host cells containing such vectors are also provided. Methods of making the fusion proteins of the invention are also provide, as well as methods of using the fusion proteins, for example to inhibit protease activity in a biological sample or in the treatment of an individual suffering from, or at risk for, a disease or disorder involving unwanted protease activity.
Bibliography:Application Number: DE20016032632T